Editorial for the Special Issue on “Nucleic Acid Architectures for Therapeutics, Diagnostics, Devices and Materials”

The use of nucleic acids (RNA and DNA) offers a unique and multifunctional platform for numerous applications including therapeutics, diagnostics, nanodevices, and materials [...].

drawbacks. Oliver et al. propose a new approach to characterizing nucleic acid nanoparticles using small angle X-ray or neutron scattering [4]. Their in-depth review examines the structural and chemical requirements for studying various biomolecules in their natural confirmations. It also highlights the multitude of requirements for solution and sample preparations, and discusses the precise data yielded from these techniques. Finally, it discusses the prospects for enhancing the characterization of nanostructured nucleic acid architectures.
Following design and characterization, advances in the use of DNA and RNA nanostructures in devices and molecular machines is highlighted in this issue. One such device is the DNA nanopore, which offers a unique membrane-bound tool for furthering biophysical research and biosensing. In this issue, Burns and Howorka describe the design and evaluation of a DNA nanopore in various biological milieu [5]. The authors identify parameters for the assembly of a hexameric DNA nanopore using gel electrophoresis and fluorescence spectroscopy, and further confirm its integrity in cell media, as well as its successful integration into lipid membranes.
Beyond the development of biophysical tools, this special issue contains two original manuscripts detailing the use of DNA and RNA nanostructures in the design of molecular logic gates. Using "light-up" malachite green and Broccoli aptamers, Goldsworthy et al. describe the design of robust and precise RNA nanodevices with several Boolean logic functions, including AND, OR, NAND, and NOR capabilities [6]. The binding of the small molecule dyes to their aptamers in the conditional situations causes a fluorescent output based strictly on the input of the designed strands. Using this approach, the authors designed and integrated parallel XOR and AND gates within a single RNA nanoparticle.
Towards that end, Zakrevsky et al. describe the use of logic gates to mimic complex molecular biological phenomena with the potential for use in cells [7]. In their research, the authors computationally design and characterize DNA/RNA hybrid-based logic gates suited for the conditional release of single-and double-stranded nucleic acids, thus displaying the possibility of therapeutic action. Their set of logic gates offers an eclectic approach inspired by molecular beacons and other trigger-responsive multi-stranded assemblies.
The concept of smart-responsive or logic-based nucleic acid nanoassemblies is further expanded in the review by Chandler and Afonin [8]. In their review, several advances in the design and function of stimuli-responsive DNA and RNA nanoconstructs are discussed, including simple trigger/activation designs of shape-switching nanoparticles with controlled immunomodulatory properties. Furthermore, they outline the potential of using these dynamic nucleic acid nanoparticles for the conditional stimulation of an immune response, which has been determined to be dependent on the structure and composition of the given nucleic acid nanoparticle.
As therapeutics, nanostructured nucleic acids hold great potential in the treatment of various maladies. Gwak and Lee describe the use of a cationic amphiphilic co-polymer nanoparticles to efficiently deliver plasmid DNA, as well as a small molecule anti-viral therapy for successful treatment of spinal cord injuries using "suicide gene therapy" [9]. The authors further describe the stability of the nanoparticles over time and demonstrate their use in animal models.
In the same regard, Caffery et al. describe in depth the possibility of treating glioblastomas with a combination of gene therapy and various nanoscale carriers [10]. Their comprehensive review discusses both the various therapeutic nucleic acids as well as the various delivery platforms to deliver these therapeutic cargos. The authors also discuss possible limitations to each of these approaches, as well as the challenges of crossing the blood brain barrier.
Finally, this special issue features a review by Sun et al. on the use of genetically encoded RNA-based molecular sensors (GERMS) [11]. The review provides a well-rounded outline of the various design principles and applications for GERMS including their most common use of intracellular imaging. The authors go on to discuss the outlook for this novel technology and potential milestones towards developing next generation RNA based sensors.
Together, this special issue details several important advancements in the field of nucleic acid nanotechnology by focusing on design and characterization, use in devices and molecular machines, and implementation into therapeutics and sensors. The works enclosed here demonstrate the various possible applications for these burgeoning technologies.
Author Contributions: J.R.H. and K.A.A. co-wrote this Editorial Letter.

Funding:
The research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R01GM120487. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.